Publications by authors named "H P Too"

Although combining 5-fluorouracil (5-FU) and Interferon-beta (IFNb) improves response rates in Hepatocellular Carcinoma (HCC), the outcomes remain suboptimal. This study investigates the feasibility of using highly transfected Mesenchymal Stem Cells (MSCs) to deliver a chemotherapeutic (5-FU) and an immunomodulator (IFNb) for localized HCC treatment. Considering the crucial role of cold-chain transportation in off-the-shelf allogeneic therapy, the study also assesses the quality and efficacy of frozen-thawed engineered MSCs, simulating a multisite study process.

View Article and Find Full Text PDF

Background: Emerging diagnostic modalities suggest that miRNA profiles within extracellular vesicles (EVs) isolated from peripheral blood specimens may provide a non-invasive diagnostic alternative for dementia and neurodegenerative disorders. Given that EVs confer a protective environment against miRNA enzymatic degradation, the miRNAs enriched in the EV fraction of blood samples could serve as more stable and clinically relevant biomarkers compared to those obtained from serum.

Objective: To compare miRNAs isolated from EVs versus serum in blood taken from Alzheimer's disease (AD) dementia patients and control cohorts.

View Article and Find Full Text PDF
Article Synopsis
  • Mesenchymal stem cells (MSCs) are being researched as potential carriers to deliver cancer treatments due to their ability to target tumors, with previous studies showing promising anti-tumor effects in mice and other animals using specific genetic engineering.
  • This study aimed to enhance cancer treatment by co-administering engineered MSCs that express two therapeutic agents (CDUPRT and IFNb) alongside a prodrug system, while assessing their effectiveness through various experiments.
  • Results indicated that the engineered MSCs maintained their migratory abilities after genetic modifications, and showed improved anti-cancer efficacy when CDUPRT and IFNb were co-expressed compared to when only CDUPRT was used.
View Article and Find Full Text PDF

Nanorobots powered by designed DNA molecular motors on DNA origami platforms are vigorously pursued but still short of fully autonomous and sustainable operation, as the reported systems rely on manually operated or autonomous but bridge-burning molecular motors. Expanding DNA nanorobotics requires origami-based autonomous non-bridge-burning motors, but such advanced artificial molecular motors are rare, and their integration with DNA origami remains a challenge. Here, we report an autonomous non-bridge-burning DNA motor tailor-designed for a triangle DNA origami substrate.

View Article and Find Full Text PDF